| Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiency G Loules, M Zamanakou, F Parsopoulou, S Vatsiou, F Psarros, D Csuka, ... Gene 667, 76-82, 2018 | 44 | 2018 |
| Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema A Valerieva, M Staevska, M Jesenak, K Hrubiskova, M Sobotkova, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (2), 799-802, 2020 | 28 | 2020 |
| A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiency S Vatsiou, M Zamanakou, G Loules, F Psarros, F Parsopoulou, D Csuka, ... Allergology International 69 (3), 443-449, 2020 | 21 | 2020 |
| Current and emerging biologics for the treatment of hereditary angioedema F Perego, MA Wu, A Valerieva, S Caccia, C Suffritti, A Zanichelli, ... Expert Opinion on Biological Therapy 19 (6), 517-526, 2019 | 21 | 2019 |
| Effect of micronized cellulose powder on the efficacy of topical oxymetazoline in allergic rhinitis A Valerieva, TA Popov, M Staevska, T Kralimarkova, E Petkova, ... Allergy Asthma Proc 36 (6), e134-139, 2015 | 20 | 2015 |
| Phenotypes determined by cluster analysis in moderate to severe bronchial asthma VM Youroukova, DG Dimitrova, AD Valerieva, SS Lesichkova, ... Folia Med 59 (2), 165-173, 2017 | 17 | 2017 |
| Therapeutic management of hereditary angioedema: past, present, and future A Valerieva, D Nedeva, V Yordanova, E Petkova, M Staevska Balkan Medical Journal 38 (2), 89, 2021 | 12 | 2021 |
| Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema A Valerieva, S Caccia, M Cicardi Expert Review of Clinical Immunology 14 (9), 707-718, 2018 | 11 | 2018 |
| Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry A Valerieva, MT Staevska, V Grivcheva-Panovska, M Jesenak, ... World Allergy Organization Journal 14 (4), 100535, 2021 | 10 | 2021 |
| Lanadelumab injection treatment for the prevention of hereditary angioedema (HAE): design, development and place in therapy M Bova, A Valerieva, MA Wu, R Senter, F Perego Drug design, development and therapy, 3635-3646, 2019 | 10 | 2019 |
| Efficacy and safety of bradykinin B2 receptor inhibition with oral PHVS416 in treating hereditary angioedema attacks: results of RAPIDe-1 phase 2 trial M Maurer, J Anderson, E Aygören-Pürsün, L Bouillet, ML Baeza, ... Journal of Allergy and Clinical Immunology 151 (2), AB134, 2023 | 8 | 2023 |
| Treatment of hereditary angioedema—single or multiple pathways to the rescue A Valerieva, HJ Longhurst Frontiers in Allergy 3, 952233, 2022 | 8 | 2022 |
| Micronized cellulose powder as a means to enhance intranasal symptoms-driven treatment: patients’ attitudes in a real life setting A Valerieva, MK Church, M Staevska, T Kralimarkova, E Petkova, ... Allergy 71 (Supplement 102), 13, 2016 | 6 | 2016 |
| Real-life study on the effect of micronized cellulose powder as add-on to intranasal as-needed treatment of subjects with pollen allergic rhinitis TA Popov, A Valerieva, MK Church, M Staevska, T Kralimarkova, ... Journal of Allergy and Clinical Immunology 137 (2), AB402, 2016 | 6 | 2016 |
| Searching for genetic biomarkers for hereditary angioedema due to C1-inhibitor deficiency (C1-INH-HAE) F Parsopoulou, G Loules, M Zamanakou, D Csuka, A Szilagyi, M Kompoti, ... Frontiers in Allergy 3, 868185, 2022 | 4 | 2022 |
| The physician and hereditary angioedema friend or foe: 62-year diagnostic delay and iatrogenic procedures A Valerieva, M Cicardi, J Baraniuk, M Staevska Allergy, Asthma & Clinical Immunology 14, 1-6, 2018 | 4 | 2018 |
| Hereditary angioedema: treatment options and availability. Balance between patients’ needs and stakeholders’ plans A Valerieva, F Perego, G Porebski, M Staevska, M Cicardi Alergia Astma Immunologia-przegląd kliniczny 23 (4), 175-185, 2018 | 4 | 2018 |
| A review of randomized controlled trials of hereditary angioedema long-term prophylaxis with C1 inhibitor replacement therapy: alleviation of disease symptoms is achievable HJ Longhurst, A Valerieva Journal of Asthma and Allergy, 269-277, 2023 | 3 | 2023 |
| Safety Aspects and Rational Use of Lanadelumab Injections in the Treatment of Hereditary Angioedema (HAE): Clinical Insights E Petkova, V Yordanova, M Staevska, A Valerieva Drug, Healthcare and Patient Safety, 195-210, 2022 | 3 | 2022 |
| Airborne contact dermatitis and hand eczema caused by 2-Hydroxyethylmethacrylate (2-Hema)-case report of occupational contact allergy D Nedeva, E Petkova, A Valerieva, S Uzunov, B Krusheva, M Staevska Allergy 74, 499-499, 2019 | 3 | 2019 |
